Study Evaluating Long-Term Safety Of ATN-103 In Subjects With Rheumatoid Arthritis

Update Il y a 4 ans
Reference: NCT01063803

Woman and Man

Extract

This open-label extension study will allow subjects who have completed either the 3242K1-2000-WW or 3242K1-2001-JA study to receive up to an additional 48 weeks of ATN-103 treatment and will provide data on the long-term safety and tolerability of ATN-103 in subjects with rheumatoid arthritis.


Inclusion criteria

  • Rheumatoid Arthritis


Links